Home / Products / Others

Ipidacrine hydrochloride hydrate

Name: Ipidacrine hydrochloride hydrate
Brand: Smolecule
SKU: S623535
Rating: 4 (5 reviews)

Catalog No.

S623535

CAS No.

118499-70-0

M.F

C12H19ClN2O

M. Wt

242.74 g/mol

Availability

In Stock

* This item is exclusively intended for research purposes and is not designed for human therapeutic applications or veterinary use.

3. Others

General Information

CAS Number

118499-70-0

Product Name

Ipidacrine hydrochloride hydrate

IUPAC Name

2,3,5,6,7,8-hexahydro-1H-cyclopenta[b]quinolin-9-amine;hydrate;hydrochloride

Molecular Formula

C12H19ClN2O

Molecular Weight

242.74 g/mol

InChI

InChI=1S/C12H16N2.ClH.H2O/c13-12-8-4-1-2-6-10(8)14-11-7-3-5-9(11)12;;/h1-7H2,(H2,13,14);1H;1H2

InChI Key

SBTIBNSPYUUNGA-UHFFFAOYSA-N

SMILES

C1CCC2=C(C1)C(=C3CCCC3=N2)N.O.Cl

Canonical SMILES

C1CCC2=C(C1)C(=C3CCCC3=N2)N.O.Cl

Scientific Research Applications

Studies on Alzheimer's Disease

Ipidacrine was initially investigated as a potential treatment for Alzheimer's disease due to its ability to increase acetylcholine levels in the brain. Some early studies showed modest improvements in cognitive function and daily living activities in patients with mild to moderate Alzheimer's disease []. However, larger and more rigorous studies failed to replicate these findings, and the drug was not found to be effective in slowing the progression of the disease []. Due to these results, ipidacrine is not currently used as a treatment for Alzheimer's disease.

Exploring Mechanisms of Action

Despite not being a viable treatment for Alzheimer's disease, research on ipidacrine continues to explore its mechanisms of action and potential benefits in other contexts. Studies suggest that ipidacrine may have additional effects beyond inhibiting cholinesterase, such as modulating neuroinflammation and protecting nerve cells from damage [, ]. These findings warrant further investigation to understand how these mechanisms might contribute to potential therapeutic effects.

Potential Applications in Other Neurological Conditions

Based on its proposed mechanisms of action beyond cholinesterase inhibition, ipidacrine is being explored as a potential treatment for other neurological conditions. Some ongoing research areas include:

Lewy body dementia: Early studies suggest ipidacrine may improve cognitive function and motor symptoms in patients with Lewy body dementia. However, more research is needed to confirm these findings and determine its long-term efficacy and safety.
Stroke: Animal studies suggest ipidacrine may improve neurological recovery after stroke by promoting nerve cell growth and protecting brain tissue. However, clinical trials are needed to evaluate its effectiveness and safety in human stroke patients.

Others

UNII

OV96AIK79Q

GHS Hazard Statements

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.;
H318 (100%): Causes serious eye damage [Danger Serious eye damage/eye irritation];
H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure;
Respiratory tract irritation]